Since its inception in 1989 iBET has partnered with many international pharma companies in scientifically based research projects.
As our scientific and technical competences grew in excellence and trust some biopharma companies became valuable partners leading to the creation of a new concept at iBET, the Satellite laboratories.
Satellite laboratories teams are exclusively dedicated to research within the network of each company and comprise scientists jointly recruited by the company and iBET. In each Satellite laboratory the Lab Head is the gatekeeper and the one responsible for the direct communication between both entities.
Highly qualified iBET’s scientists contribute to the companies’ own R&D needs, in a flexible and fully confidential way, having access to the broader knowledge existing at iBET as well as to its “horizontal infrastructures”, like the protein production platform and the analytical services.
For iBET, this allows operating more complex infrastructures and having access to a better knowledge on unmet R&D needs, reinforcing iBET’s own internal R&D strategy.
As companies become aware of the success of iBET Satellite Laboratories, the collaboration tends to increase by challenging the teams with new ideas, enlarging the scope of the work at the Satellite Laboratories and creating new, separate R&D joint projects. iBET ensures additional flexibility to accommodate such developments by providing opportunities for the work to be performed outside of the specific Satellite Laboratory with iBET’s own teams.
Currently, four companies have Satellite Laboratories at iBET, carrying out activities in discovery or preclinical development for their pipelines: Bayer, Merck Healthcare KGaA, Novartis and Sanofi.
Satellite Laboratories heads:
- Bayer – Daniel Simão
- Merck Healthcare KGaA – Tiago Bandeiras
- Novartis – Ana Paula Batista
- Sanofi – Patrícia Gomes-Alves
